Dose-dependent progression of parkinsonism in manganese-exposed welders

Predicting progression in patients with Parkinson's disease

Lancet Neurol.

Blauwendraat C, Bandrés-Ciga S, Singleton AB

doi: 10.1016/

RECOMMENDED

Parkinson’s Disease

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

Mov Disord.

Mollenhauer B, Zimmermann J, Sixel-Döring F, Focke NK, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Friede T, Trenkwalder C; DeNoPa Study Group

doi: 10.1002/mds.27492.

Parkinson’s Disease

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression

J Neurol Neurosurg Psychiatry.

Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM

doi: 10.1136/jnnp-2018-318337.

Parkinson’s Disease

Slow-wave sleep and motor progression in Parkinson disease

Ann Neurol.

Schreiner SJ, Imbach LL, Werth E, Poryazova R, Baumann-Vogel H, Valko PO, Murer T, Noain D, Baumann CR

doi: 10.1002/ana.25459.

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Lancet Neurol.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS

doi: 10.1016/

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

Brain Neurology Journ.

Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE

doi: 10.1093/brain/awx146.

Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease

Invest Ophthalmol Vis Sci.

Satue M, Rodrigo MJ, Obis J, Vilades E, Gracia H, Otin S, Fuertes MI, Alarcia R, Crespo JA, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E

doi: 10.1167/iovs.16-20460.

Aging and Cognitive Functions

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Neurology.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M

doi: 10.1212/

Aging and Cognitive Functions

Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease

JAMA Neurol.

Paul KC, Schulz J, Bronstein JM, Lill CM, Ritz BR

doi: 10.1001/jamaneurol.

Related content

Predicting progression in patients with Parkinson's disease

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

Developing and validating Parkinson's disease subtypes and their motor and cognitive progression

Slow-wave sleep and motor progression in Parkinson disease

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease

Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease